Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ritalin 10mg tablets
0404000M0BBAAAA
|
Ritalin | Methylphenidate hydrochloride | Central Nervous System | 3,485 |
|
Ritalin XL 30mg capsules
0404000M0BBAEAV
|
Ritalin | Methylphenidate hydrochloride | Central Nervous System | 99 |
|
Ritalin XL 20mg capsules
0404000M0BBADAQ
|
Ritalin | Methylphenidate hydrochloride | Central Nervous System | 80 |
|
Ritalin XL 10mg capsules
0404000M0BBACAU
|
Ritalin | Methylphenidate hydrochloride | Central Nervous System | 73 |
|
Ritalin XL 40mg capsules
0404000M0BBAGAW
|
Ritalin | Methylphenidate hydrochloride | Central Nervous System | 55 |
|
Ritalin XL 60mg capsules
0404000M0BBAFBA
|
Ritalin | Methylphenidate hydrochloride | Central Nervous System | 1 |
|
Ritalin-SR 20mg tablets
0404000M0BBABAH
|
Ritalin | Methylphenidate hydrochloride | Central Nervous System | 1 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.